Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance.
- NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_assertion description "[Retrospective studies have demonstrated that nearly 50% of patients with ovarian cancer with normal cancer antigen 125 (CA125) levels have persistent disease; however, prospectively distinguishing between patients is currently impossible.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance.
- NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_assertion evidence source_evidence_literature NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance.
- NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_assertion SIO_000772 24563622 NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance.
- NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_assertion wasDerivedFrom befree-20150227 NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance.
- NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_assertion wasGeneratedBy ECO_0000203 NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP962795.RAzQxQo3m6k0NIGGpYD9cBEvZm77EenIRgeUSD85PyKaQ130_provenance.